The Place of Mefenamic Acid in the Treatment of Rheumatoid Arthritis

Bain L. S. Masheter H. C. (1967) Flufenamic acid and indomethacin in rheumatoid arthritis. In Fenamates in Medicine, A Symposium. Annals of Physical Medicine, Suppl. 104.

Barnado D. E. Currey H. L. F. Mason R. M. Fox W. R. Weatherall M. (1966). Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. British Medical Journal, 2, 342.

Brooks P. M. Buchanan W. W. (1976). Clinical features and treatment. In Current Management of Rheumatoid Arthritis. Recent Advances in Rheumatology. No. 1 Part II, pp. 33–87. Edited by Buchanan W. W. Dick W. C. Edinburgh: Churchill-Livingstone.

Coodley E. L. (1963). Evaluation of drug therapy in rheumatoid arthritis. A Study of Flufenamic Acid. Western Journal of Medicine, 4, 228.

Collier H. O. J. Sweatman W. J. F. (1968). Antagonism by fenamates of Prostaglandin F2α and of slow reacting substance on human bronchial muscle Nature, 219, 864.

Collier H. O. J. McDonald-Gibson W. J. Saeed S. A. (1974). Apomorphine and morphine stimulate prostglandin biosynthesis. Nature, 252, 56.

Cordoe N. (1976). A clinical trial of flufenamic acid in rheumatoid arthritis. In Fenamates in Medicine. A Symposium. Annals of Physical Medicine, Supp. 99.

Cowan I. C Masheter H. C. (1966). Flufenamic Acid in rheumatoid arthritis. A placebo controlled study. Clinical Trials Journal, 3, 503.

Haward L. R. C. (1967). Effects of fenamates on the threshold of pain. In Fenamates in Medicine. A Symposium. Annals of Physical Medicine, Supp. 55.

Hill A. G. S. (1967) Review of flufenamic acid in rheumatoid arthritis. In Fenamates in Medicine. A Symposium. Annals of Physical Medicine , Supp. 87.

Lee P. Ahola S. Crennan D. Brooks P. Buchanan W. W. (1974). Observations on drug prescribing in rheumatoid arthritis. British Medical Journal 1, 424.

Lee P. Anderson J. A. Miller J. Webb J. Buchanan W. W. (1976). Evaluation of analgesic action and efficacy of antirheumatic drugs. Journal of Rheumatism, 33, 283.

Mavrikakis M. MacLeod M. Buchanan W. W. Hernandez L. Rennie J. A. N. (1977). Mefanamic acid, an under-rated antirheumatic. Current Medical Research, Op. 4, 535.

McDonald-Gibson W. J. Saeed S. A. Schneider C. (1976). The local antinociceptive and topical anti-inflammatory effects of propyl gallate in rodents. British Journal of Pharmacology, 58, 573.

Razan K. T. Hill A. G. S. Barr A. Whitehall E. (1967). Flufenamic acid in rheumatoid arthritis. Annals of Rheumatic Diseases, 26, 43.

Simpson M. R. Simpson N. R. W. Masheter H. C. Hardy S. M. (1967). Flufenamic acid in rheumatoid arthritis: The second six months of treatment. In Fenamates in Medicine. A Symposium. Annals of Physical Medicine Supp. III.

Winder C. V. Scotti L. Scherrer R. A. Jones E. M. Short F. W. (1962). Anti-inflammatory, antipyretic and anti-nociceptive properties of N- (2, 3, xylyl) anthralinic acid (mefenamic acid). Journal of Pharmacology and Experimental Therapeutics, 138, 405.

Winder C. V. Serrano B. Jones E. M. McPhee (1963). Anti-inflammatory and antipyretic properties of N- (a,a,a,-trifluoro-m-tolyl) anthralinic acid (flufenamic acid). Arthritis and Rheumatism, 6, 36.

Winder C. V. (1965). In Non-steroidal anti-inflammatory drugs. Edited by Garattini S. Dukes M. N. G. International Congress Series No. 82, pp. 190–202. Amsterdam: Excerpta Medica Foundation.

Winder C. V. Lambie L. A. Stephens M. D. (1969). Comparative bio-assay of drugs in adjuvant induced arthritis in rats. Arthritis and Rheumatism, 12, 478.